Article Information
History
- April 13, 2021.
Copyright
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-NC 4.0 International license.
Author Information
- aDepartment of Chemistry, College of Science, University of Kufa, Iraq. E-mail: headm2010{at}yahoo.com
- bDepartment of Medical Laboratory Techniques, Altoosi University College, Najaf, Iraq. E-mail: shaima.alhmmamy{at}altoosi.edu.iq
- cDepartment of Psychiatry, Medical University of Plovdiv, Plovdiv, Bulgaria
- dDepartment of Psychiatry, Faculty of Medicine, Chulalongkorn University, Bangkok, Thailand
- eSchool of Medicine, IMPACT Strategic Research Centre, Deakin University, PO Box 281, Geelong, VIC, 3220, Australia
- ↵*Corresponding author: Prof. Dr. Michael Maes, M.D., Ph.D., IMPACT Strategic Research Center, Barwon Health, Deakin University, Geelong, Vic, Australia., E-mail: dr.michaelmaes{at}hotmail.com.
Posted April 13, 2021.
Increased serum thromboxane A2 and prostacyclin but lower complement C3 and C4 levels in COVID-19: associations with chest CT-scan anomalies and lowered peripheral oxygen saturation
